Learn About Hemophagocytic Lymphohistiocytosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Hemophagocytic Lymphohistiocytosis Local Doctors?
CD
Cristina De Min
Elite
Highly rated in
4
conditions

NovImmune SA

Basel, BS, CH 

Cristina De Min is in Basel, Switzerland. De Min is rated as an Elite expert by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. She is also highly rated in 4 other conditions, according to our data. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

View Profile
ZW
Zhao D. Wang
Elite
Highly rated in
11
conditions

Beijing Friendship Hospital, Capital Medical University

National Clinical Research Center For Hematologic Disease 
Beijing, CN 10004

Zhao Wang is in Beijing, China. Wang is rated as an Elite expert by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. They are also highly rated in 11 other conditions, according to our data. Their top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
CA
Carl E. Allen
Dr. Carl E. Allen
Pediatric Hematology Oncology
Elite
Highly rated in
9
conditions
Pediatric Hematology Oncology

Texas Childrens Hospital

Texas Medical Center

1102 Bates Ave 
Houston, TX 77030

Carl Allen is a Pediatric Hematologist Oncology doctor in Houston, Texas. Dr. Allen is rated as an Elite doctor by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Hemophagocytic Lymphohistiocytosis. He is licensed to treat patients in Texas. Dr. Allen is currently accepting new patients.

View Profile
View All Doctors
What are the Latest Advances for Hemophagocytic Lymphohistiocytosis?
Efficacy of plasma exchange in children with severe hemophagocytic syndrome: a prospective randomized controlled trial.
Condition: Children with Severe Hemophagocytic Syndrome
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Treatment Used: Plasma Exchange
Number of Patients: 40
Published: March 30, 2022
View publication
Summary: Efficacy of plasma exchange in children with severe hemophagocytic syndrome: a prospective randomized controlled trial.
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.
Condition: Mucopolysaccharidosis-Plus Syndrome (MPS-PS)
Journal: Genes
Treatment Used: Steroids
Number of Patients: 1
Published: March 25, 2022
View publication
Summary: Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.
Tired of the same old research?
Check Latest Advances
Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.
Condition: Patient with Melanoma with Hemophagocytic Lymphohistiocytosis (HLH)
Journal: Prague medical report
Treatment Used: Immunosuppressive Agents
Number of Patients: 1
Published: March 06, 2022
View publication
Summary: Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.
View All Latest Advances
What are the latest Hemophagocytic Lymphohistiocytosis Clinical Trials?
CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Who is this study for: Adult patients that are younger than 40 years old that require an Allogeneic Stem Cell Transplant
Status: Active, not recruiting
Start Date: March 2013
Intervention Type: Biological
Phase: Phase 1/Phase 2
View Trial
Summary: This study's goal is to determine the frequency and severity of acute graft versus host disease, to evaluate incidence of primary and secondary graft rejection, to assess event free survival and overall survival, to determine the time to neutrophil and platelet engraftment, to determine the time to immune reconstitution (including normalization of T, B and natural killer (NK) cell repertoire and I...
Match to trials
Find the right clinical trials for you in under a minute
Get started
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)
Status: Recruiting
Start Date: September 11, 2018
View Trial
Summary: Hemophagocytic lymphohistiocytosis in adults (HLH) is at 68% mortality whereas 78% of all cases remain undiagnosed though therapies are available which clearly reduce mortality. The investigators aim to systematically investigate this life-threatening hyperinflammatory syndrome in intensive care units (ICU) in order to detect biomarkers that are highly sensitive and highly specific for HLH in ICU ...
View All Clinical Trials